Edaravone Dexborneol tablet for CADASIL blood-brain repair
Treatments studied
Part of Brain & nervous system, Genetic & congenital, Heart & circulation clinical trials.
This trial tests an experimental tablet (placed under the tongue) to see if it can help repair the blood-brain barrier in people with CADASIL, a genetic small-vessel disease that causes stroke and thinking problems. It may help slow down damage.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed CADASIL diagnosis from a genetic test.
- You are between 18 and 80 years old.
- Your brain MRI shows at least one lacune (a small stroke cavity).
- You have not had a stroke or brain bleed in the last 3 months.
- Your current disability level is mild to moderate (can walk without full assistance).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies CADASIL (a genetic blood-vessel condition in the brain) by following people over time with MRI scans, blood draws, and questionnaires. It may help researchers better understand how the condition changes and how factors like medications affect outcomes.
This study is testing a new brain scan tool to understand small blood vessel problems in people with CADASIL. If you have CADASIL, you'll have an MRI to help develop a way to spot these changes earlier.
This study looks at how genetic and brain imaging changes relate to symptoms in people with CADASIL, a genetic condition that affects small blood vessels in the brain and can cause strokes. It aims to better understand the disease to improve future care.
This study is building a group of Australians with CADASIL (a genetic condition that affects blood vessels in the brain) to learn more about the disease. As a participant, you will have a medical exam, a blood test, and a short memory test.
This study follows people with CADASIL over time to learn more about the condition. It may help researchers understand how CADASIL progresses and improve care for patients.
This study collects blood samples and medical information from people with rare inherited blood vessel diseases of the brain, and from healthy volunteers. Researchers use this information to understand these diseases better and develop future treatments.
Hear when a new CADASIL trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.